Boston Scientific Corporation (BSX) Stock Price Today
Aura AI Summary
Key Stats
- $69.27BMarket Cap
- -Volume
- HealthSector
- $108.1452W High
- $42.6352W Low
- -Typical Hold Time
- $81.36BEnterprise Value
- -Div Yield
- -Trading Activity
Track Boston Scientific Corporation (BSX) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Boston Scientific Corporation has traded between a low of $42.63 and a high of $108.14, highlighting its annual price range. Buy and sell Boston Scientific Corporation shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Most Recent News
Oil prices hit six-week highs amid US-Iran tensions and attacks on Saudi Aramco facilities
Oil prices surged to their highest levels in six weeks as tensions escalated between the US and Iran, with both nations exchanging attacks over the weekend. Brent crude rose to $97.52 per barrel, while US West Texas Intermediate briefly surpassed $93...
VanEck Uranium and Nuclear ETF rated Buy, targeting 8-15% return amid uranium and nuclear progress
The VanEck Uranium and Nuclear ETF (NLR) is rated Buy with a target total return of 8% to 15% over the next 6 to 12 months. The fund benefits from strong uranium fundamentals and new catalysts like the U.S. Army's Janus microreactor program, with exp...
Roblox stock plunges 47% YTD, while peers Take-Two and GameStop fall less amid gaming sector struggles.
Roblox shares have dropped 47% year-to-date due to missed revenue targets and a reset in growth guidance linked to a mandatory age-check rollout. In contrast, Take-Two Interactive and GameStop stocks declined 16% and 5% respectively, reflecting less ...
People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.